CLL-105 Cumulative Incidence of Grade 3 or Higher Infections in Patients With CLL/SLL Treated With BTKi-Based Regimens
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S264-S264 - Subject
- Language
- ISSN
- 2152-2650